Netflix's "Unnatural Selection" Ducks the Big Questions About Gene Editing
By Jonathan R. Latham,
Salon
| 11. 10. 2019
The opening scene of "Unnatural Selection," a four-part docuseries released recently from Netflix, depicts scientist Jennifer Doudna showing off a tiny sample of a colorless liquid. It contains, she says, an enzyme that allows her to add or remove any piece of DNA from any living organisms. This scene launches an exploration of the people who are taking up — and talking up — that opportunity, which Doudna did much to bring about. In this scene though, as in the remainder of the series, there is scant pushback on the hyperbolic narratives tracked over the four episodes. But, having built up the potential of gene editing, "Unnatural Selection" fails to explore the qualifications and correctives that call into question the whole project of gene editing. One wonders, in fact, if the filmmakers were even aware of the larger existential questions it raises.
The protagonists of the series span an extraordinarily wide spectrum. Spark Therapeutics claims to have invented a gene therapy cure for a special kind of inherited blindness. The biotech company has chosen its smooth-talking and sharply dressed company...
Related Articles
By Anumita Kaur [cites CGS’ Katie Hasson], The Washington Post | 03.25.2025
Genetic information company 23andMe has said that it is headed to bankruptcy court, raising questions for what happens to the DNA shared by millions of people with the company via saliva test kits.
Sunday’s announcement clears the way for a new...
By Peter Wehling, Tino Plümecke, and Isabelle Bartram
| 03.26.2025
This article was originally published as “Soziogenomik und polygene Scores” in issue 272 (February 2025) of the German-language journal Gen-ethischer Informationsdienst (GID); translated by the authors.
In mid-November 2024, the British organization Hope not Hate published its investigative research ‘Inside the Eugenics Revival’. In addition to documentating an active international “race research” network, the investigation also brought to light the existence of a US start-up that offers eugenic embryo selection. Heliospect Genomics aims to enable wealthy couples to...
By Frank Landymore, Futurism | 03.18.2025
You can only throw so much money at a problem.
This, more or less, is the line being taken by AI researchers in a recent survey. Asked whether "scaling up" current AI approaches could lead to achieving artificial general...
By Craig S. Smith, Forbes | 03.08.2025
One recent evening in Shenzhen, a group of software engineers gathered in a dimly lit co-working space, furiously typing as they monitored the performance of a new AI system. The air was electric, thick with the hum of servers and...